Recent Publications and Grants

Engaged in diverse basic, translational and clinical research, our faculty routinely publish in prestigious journals and successfully compete for major grants from national funders.

Recent Publications

Research Grants

  • Collaborative Research: Control of Information Processing and Learning in Neuronal Networks through Light-mediated Programming of Genomic Networks. Yongho Bae (Co-Principal Investigator). National Science Foundation. $599,488. 2/1/2021-1/1/2024.
  • Mapping of Antibodies Derived from Plasmablasts during Kawasaki Disease. Mark Hicar (Principal Investigator). Wildermuth Memorial Foundation. $25,000. 1/1/2021-12/1/2021.
  • Optimal Arm-Bed Angle for Delivering Effective Chest Compressions. Jayasree Nair (Principal Investigator). Wildermuth Memorial Foundation. $7,500. 1/1/2021-12/1/2021.
  • School Attendance for Children with Type 1 Diabetes during the COVID Pandemic. Kathleen Bethin (Co-Principal Investigator), Lucy Mastrandrea (Co-Principal Investigator). Wildermuth Memorial Foundation. $6,700. 1/1/2021-12/1/2021.
  • Optimal Inspired Oxygen during Chest Compressions in Neonatal Resuscitation. Munmun Rawat (Principal Investigator). Eunice Kennedy Shriver National Institute of Child Health and Human Development. $159,500. 1/1/2021-12/1/2022.
  • Expanding the toolkit for design of robust phage therapeutic cocktails. Anne Kathryn Kauffman (Principal Investigator), Frank Scannapieco (Co-Investigator). NIH. $438,625. 12/1/2020-11/1/2022.
  • Environmental Health Scholar. Sarah Ventre (Principal Investigator). New York State Children’s Environmental Health Center. 11/1/2020-11/1/2022.
  • The Network Biology of Pathogen-Host Interactions Driving Exacerbation in Chronic Obstructive Pulmonary Disease (COPD). Manoj Mammen (Co-Investigator). Department of Defense, U.S. Army Medical Research and Materiel Command, Congressionally Directed Medical Research Programs. $1,057,527. 10/1/2020-8/1/2022.
  • Suramin for Radiation-Induced Oral Mucositis. Keith Kirkwood (Co-Principal Investigator). national Institutes of Health. $207,526. 9/1/2020-8/1/2022.
  • MTM 2: Collaborative Research: How does phage life history strategy govern predation in microbiomes?. Anne Kathryn Kauffman (Co-Investigator). NSF. $848,751. 9/1/2020-8/1/2025.
  • Antibody-based therapeutic to target RAGE. Ding Xu (Principal Investigator). Buffalo Innovation Accelerator Fund. $90,000. 9/1/2020-8/1/2021.
  • Impact of Advanced Therapy on Mental Health in Cystic Fibrosis (CF). Carla Frederick (Co-Investigator), Danielle Goetz (Co-Investigator). University at Buffalo Office of Research and Economic Development. $25,000. 9/1/2020-8/1/2021.
  • Evaluating Determinants of PK, Tissue Distribution, and Efficacy of siRNA-antibody Conjugates. Sukyung Woo (Principal Investigator). Center for Protein Therapeutics. $100,000. 9/1/2020-8/1/2021.
  • Planning for NIA R21/R33 Grant- Patient Driven Deprescribing to Enhance Successful Aging. Collin Clark (Co-Investigator), Christopher Daly (Co-Investigator), David Jacobs (Co-Investigator), Scott Monte (Co-Investigator), Ranjit Singh (Co-Principal Investigator), Robert Wahler (Co-Principal Investigator). US Deprescribing Research Network. $60,000. 8/1/2020-7/1/2021.
  • Identification of new or unrecognized virulence genes in hypervirulent Klebsiella pneumoniae and antivirulence genes in classical K. pneumoniae. Thomas Russo (Principal Investigator). NIH. $431,682. 8/1/2020-7/1/2022.